SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: IRWIN JAMES FRANKEL who wrote (6181)12/16/2004 3:30:44 PM
From: Harold Engstrom  Respond to of 10345
 
Huge share price increase based on Tysabri sales for BIIB? Will roughly the same # of shares outstanding, one would assume a similar increase in shareprice for Elan, but higher (due to avonex cannibalization not being an issue for Elan.) Wonder what AAB-001 will be projected to do for Wyeth?

What does your friend think about the above, Rob? Do you think he should still hold his shares or wait for your $12/share target?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News